CLDN5 and nervous system disorder: Our results suggest that loss of endothelial miR-27a-3p could be a critical event contributing to loss of claudin-5 and occludin, and therefore barrier dysfunction in neurological diseases, and restoring its expression could be a potential therapeutic strategy to preserve the barrier integrity.